Open Access
BIO Web Conf.
Volume 60, 2023
2022 4th International Conference on Biotechnology and Food Science (BFS 2022)
Article Number 02022
Number of page(s) 5
Section Agricultural Biotechnology and Food Safety
Published online 11 May 2023
  • Abrams D Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection[J]. N Engl J Med, 2009, 361(16):1548-1559. [Google Scholar]
  • Autran B Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapyon CD4+T cell homeostasis and function in advanced HIV disease[J]. Science, 1997, 277(5322):112-116. [Google Scholar]
  • Carter CC Onafuwa-Nuga A, McNamara LA, et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs[J]. Nat Med, 2010, 16(4):446-451. [Google Scholar]
  • Daniyal M Akram M, Hamid A, et al. Review: Comprehensive review on treatment of HIV[J]. Pak J Pharm Sci, 2016, 29(4):1331-1338. [Google Scholar]
  • Guihot A Bourgarit A, Carcelain G, et al. Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus[J]. Trends Immunol, 2011, 32(3):131-137. [Google Scholar]
  • HK Thaker, MH Snow. HIV viral suppression in the era of antiretroviral therapy [J]. Pos-grad Med J, 2003, 79: 36-42. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymie function with age and during the treatment of HIV infection[J]. Nature, 1998, 396 (6712):690. [Google Scholar]
  • Kolte L Ryder LP, Albrecht-Beste E, et al. HIVinfected patients with a large thymus maintain higherCD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy[J]. Scand J Immunol, 2009, 70(6):608-613. [Google Scholar]
  • Kwarteng A Ahuno ST, KwakyeNuako G. The therapeutic landscape of HIV-1 via genome editing[J]. AIDS Res Ther, 2017, 14:32. [CrossRef] [PubMed] [Google Scholar]
  • Mendez-Lagares G, Pozo-Balado MM, Genebat M, etal. Severe immune dysregulation affects CD4(+) CD25(hi)FoxP3(+) regulatory T cells in HIV-infected patients with low-level CD4T-cell repopulation despite suppressive highly active antiretroviral therapy[J]. J Infect Dis, 2012, 205(10): 1501-1509. [CrossRef] [PubMed] [Google Scholar]
  • Sabbatini F Bandera A, Ferrario G, et al. Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIVinfected patients[J]. PLoS One, 2010, 5(11):e14119. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.